Annual ROE
-887.60%
-873.55%-6217.44%
December 1, 2023
Summary
- As of February 7, 2025, ZVSA annual return on equity is -887.60%, with the most recent change of -873.55% (-6217.44%) on December 1, 2023.
- During the last 3 years, ZVSA annual ROE has fallen by -1035.81% (-698.88%).
- ZVSA annual ROE is now -698.88% below its all-time high of 148.21%, reached on December 1, 2020.
Performance
ZVSA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-224.85%
-52.34%-30.34%
September 1, 2024
Summary
- As of February 7, 2025, ZVSA quarterly return on equity is -224.85%, with the most recent change of -52.34% (-30.34%) on September 1, 2024.
- Over the past year, ZVSA quarterly ROE has increased by +404.06% (+64.25%).
- ZVSA quarterly ROE is now -359.52% below its all-time high of 86.64%, reached on September 30, 2022.
Performance
ZVSA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ZVSA ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6217.4% | +64.3% |
| 3 y3 years | -698.9% | -424.6% |
| 5 y5 years | -698.9% | -424.6% |
ZVSA ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1472.5% | at low | -359.5% | +64.3% |
| 5 y | 5-year | -698.9% | at low | -359.5% | +64.3% |
| alltime | all time | -698.9% | at low | -359.5% | +64.3% |
ZyVersa Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -224.85%(+30.3%) |
| Jun 2024 | - | -172.51%(-72.6%) |
| Mar 2024 | - | -628.91%(+136.6%) |
| Dec 2023 | -887.60%(+6217.4%) | -265.78%(+75.7%) |
| Sep 2023 | - | -151.25%(-14.1%) |
| Jun 2023 | - | -175.99%(+440.5%) |
| Mar 2023 | - | -32.56%(-43.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | -14.05%(-121.7%) | -57.75%(-166.7%) |
| Sep 2022 | - | 86.64%(+25.1%) |
| Jun 2022 | - | 69.27%(+14.0%) |
| Mar 2022 | - | 60.78%(+97.4%) |
| Dec 2021 | 64.67%(-56.4%) | - |
| Dec 2021 | - | 30.79% |
| Dec 2020 | 148.21% | - |
FAQ
- What is ZyVersa Therapeutics annual return on equity?
- What is the all time high annual ROE for ZyVersa Therapeutics?
- What is ZyVersa Therapeutics annual ROE year-on-year change?
- What is ZyVersa Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for ZyVersa Therapeutics?
- What is ZyVersa Therapeutics quarterly ROE year-on-year change?
What is ZyVersa Therapeutics annual return on equity?
The current annual ROE of ZVSA is -887.60%
What is the all time high annual ROE for ZyVersa Therapeutics?
ZyVersa Therapeutics all-time high annual return on equity is 148.21%
What is ZyVersa Therapeutics annual ROE year-on-year change?
Over the past year, ZVSA annual return on equity has changed by -873.55% (-6217.44%)
What is ZyVersa Therapeutics quarterly return on equity?
The current quarterly ROE of ZVSA is -224.85%
What is the all time high quarterly ROE for ZyVersa Therapeutics?
ZyVersa Therapeutics all-time high quarterly return on equity is 86.64%
What is ZyVersa Therapeutics quarterly ROE year-on-year change?
Over the past year, ZVSA quarterly return on equity has changed by +404.06% (+64.25%)